Controversial Issues and Challenging Cases in Hypertriglyceridemia

Curriculum:
N/A
Credits:
1 ACPE 1 ANCC Contract Hours 1 CDR 1 AMA PRA Category 1 Credit(s)™
Launch Date:
20-Aug-13
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

Peter P. Toth, MD, PhD, FCCP, FAHA, FACC, Program Chairman

Peter P. Toth, MD, PhD, FCCP, FAHA, FACC, Program Chairman
Director of Preventive Cardiology
CGH Medical Center
Sterling, IL
Professor of Clinical Family and Community Medicine
University of Illinois School of Medicine
Peoria, IL
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, MI

Dr. Toth is Director of Preventative Cardiology at CGH Medical Center in Sterling, IL. He is also Professor of Clinical Family and Community Medicine at the University of Illinois School of Medicine and Professor of Clinical Medicine at Michigan State University College of Osteopathic Medicine. He is the current President of the National Lipid Association. Dr. Toth received his medical degree from Wayne State University School of Medicine and his PhD in Biochemistry from Michigan State University. He completed residency training in Family Medicine at the University of Iowa Hospitals and Clinics. Dr. Toth has authored and co-authored over 220 publications in medical and scientific journals and textbooks. He is Editor-in-Chief of the Year in Lipid Disorders and an Associate Editor for the Year Book of Endocrinology. He is co-editor of Comprehensive Management of High Risk Cardiovascular Patients, Therapeutic Lipidology, Current Controversies in Dyslipidemia Management, Practical Lipid Management, Comprehensive Cardiovascular Care in the Primary Care Setting, Clinical Challenges in Hypertension, Cardiac Lipoglucotoxicity, and Lipoproteins in Diabetes Mellitus. He has lectured on many topics in cardiovascular medicine throughout the world.

JoAnne M. Foody, MD, FACC, FAHA

JoAnne M. Foody, MD, FACC, FAHA
Medical Director
Cardiovascular Wellness Program
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Dr. Foody is the Medical Director of the Cardiovascular Wellness Program at Brigham and Women's Hospital and an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts. She earned her medical degree from the University of Chicago Pritzker School of Medicine, completed her internship and a residency in internal medicine at Brigham and Women's Hospital, and held a fellowship in cardiology at the Cleveland Clinic Foundation. Dr. Foody's research focuses on identifying and fostering greater use of clinical strategies that prevent adverse cardiovascular events in people with and without coronary artery disease. She has had leadership roles on the National AMI and National Heart Failure projects of the Centers for Medicare & Medicaid Services. A Fellow of the American College of Cardiology (ACC) and the American Heart Association, Dr. Foody is editor of the authoritative text Preventive Cardiology and serves as Editor in Chief of CardioSmart.org, the ACC's patient website.

Harold E. Bays, MD, FTOS, FACE, FNLA

Harold E. Bays, MD, FTOS, FACE, FNLA
Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC)
Louisville, KY

Dr. Bays is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville, Kentucky. He earned his medical degree, completed his internship and residency in internal medicine, and received his fellowship in endocrinology and metabolism at the University of Louisville School of Medicine. Dr. Bays has served as an Investigator in over 400 Phase I - IV clinical trials for treatments for high cholesterol and other dyslipidemias, obesity, diabetes mellitus, hypertension, osteoporosis, and other metabolic and hormonal disorders. He has written, or served as a contributing author for, over 170 scientific manuscripts and book chapters, and authored over 100 scientific abstracts. His publications have appeared in such peer-reviewed journals as the New England Journal of Medicine, Obesity/Obesity Research, Journal of Clinical Endocrinology and Metabolism, and Cell Metabolism.

Sergio Fazio, MD, PhD, FAAP, FASCI

Sergio Fazio, MD, PhD, FAAP, FASCI
Cornelius Vanderbilt Chair of Cardiovascular Medicine
Professor of Medicine and Professor of Pathology, Immunology, and Microbiology
Chief, Section of Cardiovascular Disease Prevention
Vanderbilt University Medical Center
Nashville, TN

Dr. Fazio is the Cornelius Vanderbilt Chair of Cardiovascular Medicine, Professor of Medicine and of Pathology, Immunology and Microbiology, and Chief of the Section of Cardiovascular Disease Prevention at Vanderbilt University Medical Center in Nashville, Tennessee. Dr. Fazio earned his medical degree, completed his residency in internal medicine, and was a clinical fellow in metabolic diseases at the University of Rome [Italy]. He holds a doctorate in experimental medicine from the University of Siena and completed his research training at the University of California in San Francisco. Dr. Fazio’s clinical interest is in the management of patients with dyslipidemia. His research interests include the pathogenesis of genetic dyslipidemias, the early cellular events of atherogenesis, and gene therapy approaches to atherosclerosis. The results of his research have been published in journals such as the New England Journal of Medicine, Science, and Circulation. He is also author of several review articles and book chapters on lipid metabolism and atherosclerosis. A principal investigator on several studies sponsored by the NIH, Dr. Fazio serves on the editorial boards of Circulation Research, ATVB, and the Journal of Clinical Lipidology.

Michael Miller, MD, FACC, FAHA

Michael Miller, MD, FACC, FAHA
Professor
Departments of Medicine, Epidemiology & Public Health
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, MD

Dr. Miller is a Professor in the Departments of Medicine, Epidemiology & Public Health at the University of Maryland School of Medicine in Baltimore, Maryland. In addition, he is Director of the Center for Preventive Cardiology at the University of Maryland Medical Center. Dr. Miller earned his MD from The University of Medicine and Dentistry of New Jersey. Following a medical residency at the University of Cincinnati Hospital, he completed two fellowships at Johns Hopkins, one in lipoprotein metabolism and the second in cardiovascular disease. His major research interests are disorders of lipid and lipoprotein metabolism, molecular studies of HDL cholesterol, triglycerides and the postprandial response to dietary fat, nontraditional coronary risk factors and clinical trials to reduce atherosclerosis. Dr. Miller has authored more than 250 original articles, book chapters and other publications. Original research articles have appeared in the BMJ, Circulation, JACC, JAMA, NEJM, PNAS, and Science. He is the co-author of The Practice of Coronary Disease Prevention and the AMA Guide to Preventing and Treating Heart Disease.
1. Describe the pharmacologic differences among the omega-3 fatty acid agents
2. Assess the potential of new and emerging therapeutic approaches to manage hypertriglyceridemia
3. Recommend treatment strategies for patients with hypertriglyceridemia based upon evaluation of recent clinical trials
4. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families